FDA Inspection
National Blood Testing Partners, Inc.National Blood Testing Partners, Inc. – FDA Inspection, Jan 23, 2026
Record Details
This FDA Inspection record concerns National Blood Testing Partners, Inc., with an inspection on January 23, 2026, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · 79ec32ee-4b88-4b2d-9ba1-20953c666cc6
Inspection Facts
- Inspection number
- 1299452
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 1271.200(a)Capable of valid results
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 606.100(b)SOPs for investigations, records
- 21 CFR 606.100(c)Thorough investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of National Blood Testing Partners, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 30, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for National Blood Testing Partners, Inc.
- FDA Inspection 1203577 - 2023-03-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.